These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8839609)

  • 1. New treatments for multiple sclerosis: a clinical perspective.
    Thompson AJ; Noseworthy JH
    Curr Opin Neurol; 1996 Jun; 9(3):187-98. PubMed ID: 8839609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of multiple sclerosis: recent trials and future perspectives.
    Noseworthy JH; Gold R; Hartung HP
    Curr Opin Neurol; 1999 Jun; 12(3):279-93. PubMed ID: 10499173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Causal therapy of multiple sclerosis].
    Pöhlau D; Rieks M; Postert T; Hoffmann V; Przuntek H
    Dtsch Med Wochenschr; 1996 Nov; 121(45):1407-14. PubMed ID: 8964231
    [No Abstract]   [Full Text] [Related]  

  • 4. New treatments for multiple sclerosis.
    Kilpatrick TJ; Soilu-Hänninen M
    Aust N Z J Med; 1999 Dec; 29(6):801-10. PubMed ID: 10677125
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug treatment in multiple sclerosis--1995].
    Achiron A
    Harefuah; 1995 Dec; 129(12):579-83. PubMed ID: 8682363
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection.
    Neuhaus O; Archelos JJ; Hartung HP
    Trends Pharmacol Sci; 2003 Mar; 24(3):131-8. PubMed ID: 12628358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenous immunoglobulins (IVIg) in the treatment of multiple sclerosis].
    Achiron A; Miron S
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S41-4. PubMed ID: 10896988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis: a review of existing therapy and future prospects.
    Khan OA
    J Pak Med Assoc; 1996 Jan; 46(1):20-4. PubMed ID: 8830165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulins in multiple sclerosis.
    Lisak RP
    Neurology; 1998 Dec; 51(6 Suppl 5):S25-9. PubMed ID: 9851727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulin for multiple sclerosis.
    Poser CM
    Lancet; 1997 Apr; 349(9059):1177-8. PubMed ID: 9113039
    [No Abstract]   [Full Text] [Related]  

  • 11. How should we proceed with disease-modifying treatments for multiple sclerosis?
    Andersson PB; Waubant E; Goodkin DE
    Lancet; 1997 Mar; 349(9052):586-7. PubMed ID: 9057726
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy in multiple sclerosis, Part 2.
    Becker CC; Gidal BE; Fleming JO
    Am J Health Syst Pharm; 1995 Oct; 52(19):2105-20; quiz 2132-4. PubMed ID: 8535945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immunoglobulin treatment in multiple sclerosis.
    Francis G
    Neurology; 1999 Jan; 52(1):214. PubMed ID: 9921885
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous immunoglobulin treatment in multiple sclerosis.
    Gadoth N; Melamed E; Miller A; Steiner I; Abramsky O
    Neurology; 1999 Jan; 52(1):214-5. PubMed ID: 9921886
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis].
    Cazzato G; Antonello RM; Zorzon M; Torre P; Zivadinov R; Moretti R; Bragadin LM; De Masi R; Nasuelli D
    Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferons in the treatment of multiple sclerosis: do they prevent the progression of the disease?
    Rice G; Ebers G
    Arch Neurol; 1998 Dec; 55(12):1578-80. PubMed ID: 9865805
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous immunoglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis--the Israeli experience. MS Study Group.
    Achiron A; Rotstein Z; Barak Y; Sarova-Pinhas I
    Mult Scler; 1997 Apr; 3(2):142-4. PubMed ID: 9291169
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of multiple sclerosis with IVIg: potential effects and methodology of clinical trials.
    Sørensen PS
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):62-4. PubMed ID: 7964858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic interferon therapy for multiple sclerosis. Design of a trial.
    Johnson KP
    Arch Neurol; 1983 Oct; 40(11):681-2. PubMed ID: 6194777
    [No Abstract]   [Full Text] [Related]  

  • 20. Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group.
    Fazekas F; Deisenhammer F; Strasser-Fuchs S; Nahler G; Mamoli B
    Lancet; 1997 Mar; 349(9052):589-93. PubMed ID: 9057729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.